Focused Alpha’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Focused Alpha's GILD Position: Q3 2026 in Review
Focused Alpha increased its Gilead Sciences (GILD) stake by 4.4% in Q3 2026, buying an estimated $56.4K and bringing the position to 9,436 shares worth $1.41M. The position accounts for 0.35% of the portfolio, ranked #52.
Focused Alpha first reported a position in GILD in Q4 2025 and has held it in 4 quarters since. 2,060 funds tracked by Wall St. Rank hold GILD as of Q3 2026.
- Focused Alpha held 9,436 shares of Gilead Sciences worth $1.41M as of Q3 2026.
- Focused Alpha bought 402 Gilead Sciences shares in Q3 2026, an estimated $56.4K.
- Gilead Sciences made up 0.35% of Focused Alpha's portfolio in Q3 2026, its #52 holding.
- Focused Alpha first reported a position in Gilead Sciences in Q4 2025 and has held it in 4 quarters since.
- 2,060 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.
Based on Focused Alpha's 13F filing for Q3 2026, filed 20 Oct 2026.